A novel ceRNA-immunoregulatory axis based on immune cell infiltration in ulcerative colitis-associated colorectal carcinoma by integrated weighted gene co-expression network analysis

Table 3 Potential drugs with therapeutic potential for ulcerative colitis-associated colorectal cancer

Cmap name	Mean	N	Enrichment score	p	Specificity score	Percent non-null
Metronidazole	− 0.37	5	− 0.836	0.00032	0	80
3-Acetamidocoumarin	− 0.252	4	− 0.819	0.00203	0.039	50
Heptaminol	− 0.281	5	− 0.735	0.00272	0.0206	60
Isometheptene	− 0.23	4	− 0.799	0.00322	0.0138	50

ISSN: 1471-230X